AI assistant
Sending…
Coloplast — Director's Dealing 2017
Sep 12, 2017
3358_rns_2017-09-12_8ea2dce1-72d2-478a-801d-5fe1d2cff32f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Colorplast
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
Nasdaq Copenhagen
12 September 2017
Coloplast A/S
Holtedam 1
3050 Humlebæk
Denmark
Tel: +45 4911 1111
www.coloplast.com
CVR-nr. 69749917
Report on transactions of executives and related parties in Coloplast shares and related securities
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns the sale of shares.
| Name | Martin Giørtz Müller |
|---|---|
| Reason | Member of the Board |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Shares |
| Transaction | Sale of shares |
| Trade date | 12 September 2017 |
| Market | Nasdaq Copenhagen |
| Number | 110 |
| Transaction value per share in DKK | 514.00 |
| Transaction value in DKK | 56,540 |
Kind regards,
Coloplast A/S
Anne-Sofie Søegaard
This information is available in Danish and in English, in case of doubt the Danish version prevails.
For further information: Anne-Sofie Søegaard, tel. +45 4911 1924.
More from Coloplast
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23
Earnings Release
2026
Apr 23